BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20830210)

  • 1. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.
    Gilbert GL; Cretikos MA; Hueston L; Doukas G; O'Toole B; Dwyer DE
    PLoS One; 2010 Sep; 5(9):e12562. PubMed ID: 20830210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.
    Cox CM; Goodin K; Fisher E; Dawood FS; Hamilton JJ; Leparc GF; Gray M; Nelson L; Borse RH; Singleton JA; Reed C; Balish AL; Katz JM; Hopkins RS; Fry AM
    PLoS One; 2011; 6(12):e29301. PubMed ID: 22206008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.
    Booy R; Khandaker G; Heron LG; Yin J; Doyle B; Tudo KK; Hueston L; Gilbert GL; Macintyre CR; Dwyer DE
    Med J Aust; 2011 Jan; 194(1):19-23. PubMed ID: 21449863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
    Xu C; Bai T; Iuliano AD; Wang M; Yang L; Wen L; Zeng Y; Li X; Chen T; Wang W; Hu Y; Yang L; Li Z; Zou S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Widdowson MA; Shu Y
    PLoS One; 2011 Apr; 6(4):e17919. PubMed ID: 21533034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
    Skowronski DM; Hottes TS; McElhaney JE; Janjua NZ; Sabaiduc S; Chan T; Gentleman B; Purych D; Gardy J; Patrick DM; Brunham RC; De Serres G; Petric M
    J Infect Dis; 2011 Jan; 203(2):158-67. PubMed ID: 21288814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009.
    Dellagi K; Rollot O; Temmam S; Salez N; Guernier V; Pascalis H; Gérardin P; Fianu A; Lapidus N; Naty N; Tortosa P; Boussaïd K; Jaffar-Banjee MC; Filleul L; Flahault A; Carrat F; Favier F; de Lamballerie X
    PLoS One; 2011; 6(9):e25738. PubMed ID: 21980532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1.
    Kwok KO; Riley S; Perera RAPM; Wei VWI; Wu P; Wei L; Chu DKW; Barr IG; Malik Peiris JS; Cowling BJ
    BMC Infect Dis; 2017 May; 17(1):337. PubMed ID: 28494805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.
    Marcelin G; DuBois R; Rubrum A; Russell CJ; McElhaney JE; Webby RJ
    PLoS One; 2011; 6(10):e26335. PubMed ID: 22039464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
    McVernon J; Laurie K; Faddy H; Irving D; Nolan T; Barr I; Kelso A
    Influenza Other Respir Viruses; 2014 Mar; 8(2):194-200. PubMed ID: 24382379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and serological surveillance of human pandemic influenza A virus infections during 2009-2010 in Thailand.
    Prachayangprecha S; Makkoch J; Vuthitanachot C; Vuthitanachot V; Payungporn S; Chieochansin T; Theamboonlers A; Poovorawan Y
    Jpn J Infect Dis; 2011; 64(5):377-81. PubMed ID: 21937818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay.
    Yuan Q; Cheng XD; Yang BC; Zheng QB; Chen YX; Chen QR; Zeng F; Zhang R; Ge SX; Hao XK; Chen H; Zhang J; Xia NS
    Clin Microbiol Infect; 2011 Oct; 17(10):1574-80. PubMed ID: 21054661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A humoral immunity survey following the 2012 influenza season after the pH1N1 pandemic in Guangzhou, China.
    Huang P; Liang LJ; Huang ZZ; Zhang X; Yu SY; Su WZ; Ou CQ; Fang L; Cao DL; Zhang YH; Ke CW
    Viral Immunol; 2014 Apr; 27(3):124-8. PubMed ID: 24702517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Niño D; Wells JM; Arden N; Cheung S; Belmont JW
    Clin Infect Dis; 2012 Feb; 54(3):311-7. PubMed ID: 22075792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period.
    Dudareva S; Schweiger B; Thamm M; Höhle M; Stark K; Krause G; Buda S; Haas W
    PLoS One; 2011; 6(6):e21340. PubMed ID: 21701598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.
    Zhou Y; Ng DM; Seto WH; Ip DK; Kwok HK; Ma ES; Ng S; Lau LL; Peiris JS; Cowling BJ
    PLoS One; 2011; 6(11):e27169. PubMed ID: 22102878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.